Advisory Committees

December 2, 2014: Blood Products Advisory Committee Meeting Draft Agenda

Center for Biologics Evaluation and Research
111th Meeting of the Blood Products Advisory Committee
Great Room, Building 31
FDA White Oak Campus
10903 New Hampshire Avenue
Silver Spring, MD 20993

December 2-3, 2014

Draft Agenda: Tuesday, December 2, 2014
Time Presentation/ Presenter
8:30 a.m. Call to Order and Opening Remarks
Introduction of Committee

Brooks Jackson, M.D., MBA
Chair, BPAC
  Conflict of Interest Statement
Bryan Emery, LCDR
Designated Federal Officer, BPAC
  Topic I: Scientific Considerations Related to Reconsideration of the Current Blood Donor Deferral Policy for Men Who Have Had Sex with Another Man (MSM) Even One Time Since 1977
8:40 a.m. Introduction and Overview of Data Presented at the November 13, 2014 HHS Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
Alan Williams, Ph.D.
9:20 a.m. Recommendations of the November 13, 2014 Meeting of the HHS ACBTSA
James Berger
9:30 a.m. U.S. Donor Marker and Risk Factor Monitoring Program: Building on the REDS-II Transfusion-Transmitted Retrovirus and Hepatitis Virus Rates and Risk Factors Study
Simone Glynn, M.D., M.Sc.,
10:00 a.m. BREAK
10:15 a.m. Strategies to Monitor HIV Incidence and Recency in Blood Donors
Don Brambilla, Ph.D.
Research Triangle Institute International

Michele Owen, Ph.D.
11:15 a.m. Questions for Speakers
11:30 a.m. Open Public Hearing
12:30 p.m. Lunch
1:30 p.m. Open Committee Discussion
Questions for the Committee
2:30 p.m. BREAK
  Committee Updates:
2:45 p.m. Ebola Virus and Potential Implications for Blood Safety
Gerardo Kaplan, Ph.D.
3:00 p.m. Adjournment

Page Last Updated: 11/26/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English